黑色素瘤
假种皮
抗氧化剂
红豆杉
药理学
癌症
治疗效果
表皮生长因子
癌症研究
化学
医学
生物
内科学
生物化学
受体
植物
食品科学
作者
Daria Antonia Dumitraș,Alexandra Dreancă,Emőke Páll,Adrian Florin GAL,Vasile Rus,Andreea Georgiana Morohoschi,Mihaela Cotul,Monica Irina Nan,Sanda Andrei
出处
期刊:Antioxidants
[Multidisciplinary Digital Publishing Institute]
日期:2022-11-16
卷期号:11 (11): 2264-2264
被引量:15
标识
DOI:10.3390/antiox11112264
摘要
Malignant melanoma is the most aggressive type of skin cancer, and due to the numerous limitations of current treatment methods, there is an urgent need to develop novel approaches for both the prevention and treatment of malignant melanoma, with research-oriented bioactive substances representing a notable first step. The current study decided to expand on previous rhodoxanthin research by investigating the possible anti-tumor effect as well as the effect on the antioxidant status in the case of murine melanoma in an experimental model. The 21-day study was carried out on female C57BL/6J mice. On the first day of the experiment, they were subcutaneously inoculated with 106 B16F10 cells and were given rhodoxanthin orally until the end of the study. Rhodoxanthin supplementation significantly reduced tumor growth (42.18%) and weight (15.74%). Furthermore, the epidermal growth factor (EGF) activity was reduced and the concentration of 8-OHdG dropped in the treated melanoma-bearing mice compared to the untreated ones, demonstrating the role of rhodoxanthin in slowing tumor growth, one of the mechanisms being the reduction of EGF level and the decrease of DNA oxidation. The administration of rhodoxanthin determined variations in antioxidant enzymes, both at the plasma level and at the tissue level.
科研通智能强力驱动
Strongly Powered by AbleSci AI